Quarterly report pursuant to Section 13 or 15(d)

Warrants (Tables)

v3.21.1
Warrants (Tables)
3 Months Ended
Mar. 31, 2021
Convertible Notes Payable  
Schedule of warrant

 

 

Number of

Shares

 

 

Weighted Average

Exercise

Price

 

 

Weighted Average Remaining Contractual Life (years)

 

 

Aggregate

Intrinsic

Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

January 1, 2021

 

 

5,595,378

 

 

$

0.63

 

 

 

2.85

 

 

$

314,260

 

Grants

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercises

 

 

(1,030,166

)

 

$

0.42

 

 

 

-

 

 

 

-

 

Expirations

 

 

(280,212

)

 

$

0.35

 

 

 

-

 

 

 

-

 

March 31, 2021

 

 

4,285,000

 

 

$

0.70

 

 

 

3.23

 

 

$

2,013,950

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrants exercisable at:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2021

 

 

4,285,000

 

 

$

0.70

 

 

 

3.23

 

 

$

2,013,950

 

Summary of common stock warrants outstanding

Outstanding and Exercisable

Exercise Price

 

 

Number Outstanding

 

 

Weighted Average Remaining 

Contractual Life (years)

 

 

Weighted Average Exercise Price

 

$

0.70

 

 

 

4,285,000

 

 

 

3.23

 

 

$

0.70

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.70

 

 

 

4,285,000

 

 

 

3.23

 

 

$

0.70